According to CoinMeta, OpenAI announced a collaboration with PerturbAI and the Scripps Research Institute to utilize thousands of AI agents based on GPT-Rosalind to analyze experimental data from millions of mouse brain cells within 32 minutes. This analysis aimed to identify potential correlations between genetic disruptions and cellular responses, and to propose new research directions in conjunction with scientific literature. OpenAI stated that if humans were to conduct analyses and literature reviews of the same scale, it would likely take several months to a year. In blind tests, human experts preferred reports generated by multiple agents over those from a single agent in 75% of cases. The study also suggested a possible link between cholesterol regulation and neurodegenerative diseases, although these hypotheses still require further experimental verification.